Share

May 27, 2014; 82 (21) Article

Peripheral hypoxia in restless legs syndrome (Willis-Ekbom disease)

Aaro V. Salminen, Ville Rimpilä, Olli Polo
First published April 30, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000454
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
350

Share

Article Information

vol. 82 no. 21 1856-1861
DOI: 
https://doi.org/10.1212/WNL.0000000000000454
PubMed: 
24789861
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received November 9, 2013
  • Accepted in final form February 12, 2014
  • First Published April 30, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Aaro V. Salminen, MSc,
    2. Ville Rimpilä, MSc and
    3. Olli Polo, MD, PhD
  1. Aaro V. Salminen, MSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Ville Rimpilä, MSc and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Olli Polo, MD, PhD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Pfizer Inc, lecture fee, (2) ResMed, lecture fee, (3) GlaxoSmithKline plc, lecture fee

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Tuberculosis Foundation of Tampere, Finland

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the University of Tampere (A.V.S., V.R., O.P.), School of Medicine; Unesta Research Centre (A.V.S., V.R., O.P.), Tampere; and Department of Respiratory Medicine (O.P.), Tampere University Hospital, Finland.
  1. Correspondence to Aaro V. Salminen: aaro.salminen{at}unesta.fi
View Full Text

Article usage

Article usage: April 2014 to July 2019

AbstractFullPdfSource
Apr 20143004Highwire
May 2014297870113Highwire
Jun 2014133013265Highwire
Jul 20142893819Highwire
Aug 20141391925Highwire
Sep 2014139168Highwire
Oct 201499179Highwire
Nov 2014108207Highwire
Dec 201466163Highwire
Jan 20159635Highwire
Feb 20155465Highwire
Mar 20155833Highwire
Apr 20154254Highwire
May 201542104Highwire
Jun 20151902Highwire
Jul 20153201Highwire
Aug 20154953Highwire
Sep 20153000Highwire
Oct 20154295Highwire
Nov 201541911Highwire
Dec 20155321Highwire
Jan 20163530Highwire
Feb 20165032Highwire
Mar 20164031Highwire
Apr 20162111Highwire
May 20164334Highwire
Jun 20162100Highwire
Jul 20164101Highwire
Aug 20164910Highwire
Sep 20163434Highwire
Oct 20163432Highwire
Nov 20163212Highwire
Dec 20162701Highwire
Jan 20172001Highwire
Feb 20173011Highwire
Mar 20173901Highwire
Apr 20173601Highwire
May 20173900Highwire
Jun 20173101Highwire
Jul 20173521Highwire
Aug 20172602Highwire
Sep 20172700Highwire
Oct 20176311Highwire
Nov 20172700Highwire
Dec 20172900Highwire
Jan 20182112Highwire
Feb 20182311Highwire
Mar 20181321Highwire
Apr 20182111Highwire
May 20181000Highwire
Jun 20184212Highwire
Jul 20182100Highwire
Aug 20183200Highwire
Sep 20182500Highwire
Oct 20183601Highwire
Nov 20184912Highwire
Dec 20183822Highwire
Jan 20194314Highwire
Feb 20193200Highwire
Mar 20193442Highwire
Apr 20195054Highwire
May 20192711Highwire
Jun 20193111Highwire
Jul 20192822Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

More Online

CME Course

Related Articles

Topics Discussed

Alert Me